KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Other Non-Current Liabilities (2017 - 2025)

Novartis Ag (NVS) has disclosed Other Non-Current Liabilities for 9 consecutive years, with $4.1 billion as the latest value for Q4 2025.

  • Quarterly Other Non-Current Liabilities rose 1.42% to $4.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.1 billion through Dec 2025, up 1.42% year-over-year, with the annual reading at $4.1 billion for FY2025, 1.42% up from the prior year.
  • Other Non-Current Liabilities hit $4.1 billion in Q4 2025 for Novartis Ag, up from $4.1 billion in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $4.1 billion in Q4 2025 to a low of $804.0 million in Q4 2023.
  • Historically, Other Non-Current Liabilities has averaged $2.2 billion across 5 years, with a median of $956.0 million in 2021.
  • Biggest five-year swings in Other Non-Current Liabilities: fell 8.58% in 2022 and later soared 406.84% in 2024.
  • Year by year, Other Non-Current Liabilities stood at $956.0 million in 2021, then decreased by 8.58% to $874.0 million in 2022, then fell by 8.01% to $804.0 million in 2023, then skyrocketed by 406.84% to $4.1 billion in 2024, then rose by 1.42% to $4.1 billion in 2025.
  • Business Quant data shows Other Non-Current Liabilities for NVS at $4.1 billion in Q4 2025, $4.1 billion in Q4 2024, and $804.0 million in Q4 2023.